CP
PDEX icon

Covalent Partners’s Pro-Dex PDEX Stock Holding History

Covalent Partners’s Portfolio PDEX Stock Details PDEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,053
Closed -$247K – 15
2024
Q1 		$247K Sell
14,053
-1,600
-10% -$30.2K 1.89% 8
2023
Q4 		$274K Sell
15,653
-4,768
-23% -$79.7K 1.2% 9
2023
Q3 		$321K Hold
20,421
– – 1.03% 12
2023
Q2 		$390K Hold
20,421
– – 1.41% 12
2023
Q1 		$335K Sell
20,421
-4,579
-18% -$76.3K 0.75% 13
2022
Q4 		$398K Hold
25,000
– – 0.45% 15
2022
Q3 		$443K Buy
25,000
+5,001
+25% +$85.8K 0.63% 23
2022
Q2 		$319K Sell
19,999
-1
-0% -$15 0.4% 26
2022
Q1 		$331K Hold
20,000
– – 0.28% 35
2021
Q4 		$464K Hold
20,000
– – 0.39% 38
2021
Q3 		$513K Buy
+20,000
New +$568K 0.85% 29

Other funds holding PDEX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Covalent Partners's PDEX Position: Q2 2024 in Review

Covalent Partners sold out of Pro-Dex (PDEX) in Q2 2024, closing a stake of 14,053 shares — an estimated $247K sold.

Covalent Partners first reported a position in PDEX in Q3 2021 and held it in 11 quarters. The position peaked at $513K in Q3 2021. 25 funds tracked by Wall St. Rank hold PDEX as of Q2 2024.

  • Covalent Partners reported no remaining Pro-Dex position as of Q2 2024 after selling out during the quarter.
  • Covalent Partners sold 14,053 Pro-Dex shares in Q2 2024, an estimated $247K.
  • Covalent Partners first reported a position in Pro-Dex in Q3 2021 and held it in 11 quarters.
  • Covalent Partners's Pro-Dex position peaked at $513K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Pro-Dex as of Q2 2024.

Based on Covalent Partners's 13F filing for Q2 2024, filed 14 Aug 2024.